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Studies of the actions of narcotic alkaloids on bac- 
terial and mammalian cells have shown that levallor- 
phan and related compounds are potent inhibitors of 
RNA synthesis. At low concentrations, these drugs 
appear to inhibit RNA synthesis rather selectively [1, 
21 and to induce in Escherichia coli a loss of cellular 
polyamines [3]. Higher concentrations lead to the in- 
hibition of protein synthesis [4,5] and produce a 
decrease in the intracellular levels of ATP [4]. The 
inhibition of RNA synthesis in E. coli has been re 
ported to involve chiefly the various species of ribo- 
somal RNA, including the 5 S component [6] ; the 
formation of sRNA and the rapidly labeled, presuma- 
bly mRNA are more resistant to the effect of the drugs. 
These’observations all suggested the some aspect of 
nuclear functions or of genetic transcription, i.e. DNA- 
directed RNA synthesis, might be the primary site of 
action of levallorphan. Since the formation of RNA of 
some RNA viruses differs from that of the host with 
respect o the template, polymerizing enzyme and cel- 
lular localization, we have studied the effect of leval- 
lorphan on the RNA synthesis of an RNA virus, 
Mengovirus. The results how that the synthesis of 
Mengoviral RNA is at least as sensitive to levallorphan 
as host cell RNA synthesis. 
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Mouse fibroblasts (strain L-929) were maintained 
and propagated inPetri dishes using Eagle’s medium, 
according standard procedures [7]. When the incorpo- 
ration of radioactive precursors into nucleic acids was 
measured experiments were performed at a density of 
2 X 16 cells per Petri dish (60 mm diameter). 
The data in fig. 1 illustrate the effect of levallorphan 
on nucleic acid synthesis. RNA and DNA synthesis are 
Fig. 1. Levallorphsn is added to tibroblast monolayers (2 X 
105 cells in 60 mm Petri dishes containing 5 ml of medium) 
followed after 15 min by 3Hguanosine (1.7 &ml; 2 @i/ml). 
At the indicated times the medium is removed, the cells wash- 
ed and harvested. The incorporation of radioactive precursors 
into DNA (right) and RNA (left) is followed according to the 
procedure of Acs et al. [ 81. Levallorphan: M none; A---A 
2.5 x lo-4 M; - 5 x 104 M; x-x 1 x 10-3 M. 
* Present address: Commissariat il L’Energie Atomique Service 
de Biologie B.P. No. 2 Gif-sur-Yvette Saclay, France. 
nearly equally sensitive to the drug and are completely 
suppressed at10-3 M levallorphan. These findings are 
similar to those previously reported by Greene and 
Magasanik at 5 X 10m3 M levallorphan [4] . These 
authors also reported that such a levallorphan concen- 
tration caused a depletion of the ATP level in HeLa 
cells. It therefore appeared important o establish 
whether the inhibition of DNA-dependent RNA syn- 
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Table 1 
Effect of levallorphan on free adenine nucleotide pool. Levallorphan 7.5 X 104 M was added to 8 X 105 plated cells (total incu- 
bation medium 3 ml) followed 10 min later by 3H-adenosine 0.2 &ml, 2 &ml, 2 &i/ml. After various periods of time, the celis 
still attached were washed five times with cold isotonic buffer to remove extracelhtlar label and collected. The cells were washed 
again three times by suspension and centrifugation and suspended fmally into 0.25 M perchloric acid for 30 min with occasional 
shaking. After centrifugation, 0.1 ml of the supematant was mixed with 4 ml ethanol and 15 ml scintillation fluid and counted. 
Another aliquot of 0.1 ml was used for optical density measurement at 260 mn. 0.05 ml was used for paper electrophoresis, citrate- 
phosphate buffer pH 3.5,2000 V, 90 min. 
A: Total radioacfivify (cpmlml extract) 
Nucleotide Levallorphsn 60 min 190 min 320 min 
Total 0 21,930 23,640 16,153 
7.5 x lo-4 M 19,460 22,600 28,780 
B: Disfribufion of radioactivity in adenine nucleotides 
cpm/O.OS ml 
extract 
relative pool cpm/O.OS ml relative pool cpm10.05 ml relative 
size AMP= 1 .OO extract size AMPz1.00 extract pool size 
AMP=l.OO 
AMP 0 742 1.00 968 1.00 615 1.00 
ADP 1,257 1.69 1,114 1.15 928 1.51 
ATP 2,220 2.95 1,618 1.67 1,074 1.74 
AMP 336 1.00 897 1.00 617 1.00 
ADP 7.5 x IO-4 M 849 2.52 1,350 1.51 1,160 1.88 
ATP 1,408 4.18 1,654 1.73 1,850 3.00 
Monolayers of L-cells (8 X 105 cells per Petri dish of 60 mm dieter) were incubated at 37OC in 3 ml of Eagle’s medium con- 
taining 5% fetal calf serum. Levallorphan (7.5 X 10401 final concentration) was added; after 10 min incubation by 3H-adenosine 
(final concentration 0.2 g/ml, 2 Ci/ml), Petri dishes were removed and processed at the indicated times. The incubation medium 
was aspirated, the monolayers washed three times with successive 3ml aliquots of phosphate-buffered saline (PBS) (pH 7.2). The 
cells were detached from the surface of the Petri dish in the cold with a rubber policeman in the presence of PBS containing 0.02% 
wsin, and harvested by centrifugation. The cell pellet was washed three times by recentrifugation from 5 ml aliquots of PBS at 
0 C. The final pellet was resuspended in 0.3 ml of 0.25 M perchloric acid, maintained on ice with occasional shaking for 30 mm, and 
recentrifuged. The UV absorption and radioactivity of the supematant extract were determined; an aliquot (0.05 ml) was analyzed 
by high voltage electrophoresis, (0.05 M citrate-phosphate buffer, pH 3.5,2000 V, 90 min) in the presence of known marker com- 
pounds. The zones corresponding to AMP, ADP and ATP were isolated and their radioactivity measured in a scintillation counter. 
The specific radioactivities of ah adenine nucleotides were identical to within f 50%; thus a comparison of the radioactivity in each 
fraction provides a measure of the relative sizes of the different pools. In the table these pools are all normalized to that of AMP 
which is arbitrarily taken as 1.00. 
thesis could be dissociated from this effect. As seen in 
table 1,7.5 X Ia4 M lewalorphan did not affect 
either the phosphorylation of adenosine, its conver- 
sion to AMP, ADP and ATP, or the relaive proportions 
of the various adenine nucleotides in the acid soluble 
pool. 
To test for the susceptibility to levallorphan of 
virus directed functions, the cells were first pretreated 
with actinomycin and then infected with a high mul- 
tiplicity of Mengovirus. Levallorphan was added either 
one or four hours after infection to permit the forma- 
mation of at least some of the virus specific RNA syn- 
thetase in the latter case, and viral RNA synthesis was 
then followed by the incorporation of 3H-uridine into 
RNA. As seen in fig. 2, concentrations of levallorphan 
which did not affect cellular ATP levels (5 X 10m4 to 
7.5 X ICY4 M) strongly inhibited or suppressed the syn- 
thesis of viral RNA. At the few concentrations tested, 
the synthesis of viral RNA is inhibited by levallorphan 
at least to the same xtent as that of RNA in uninfected 
cells. 
We do not know the mechanism by which levallor- 
191 
Volume 6, number 3 FEBS LETTERS February 1970 
20, 
9 . 
e I@- 
: lb- 
E _ 
a 
& 14- 
12- 
IO- 
b- 
10, 
P - 
= 9- 
% 
Q - 
I 
0 l._?GY. LL!__ ___A&---44 0 _.___*--.-w--x 
0 1 2 3 4 5 6 7hrs 0 1 2 3 4 Shrs 
Fig. 2. Effect of levallorphan on Mengoviral RNA synthesis. 
Petri dishes (60 mm diameter) contain 2 X 105 frbroblasts in 
monolayer culture and 3 ml of culture medium. Actinomycin 
D (2-3 &ml) ia added, followed after 20 min by a concen- 
trated suspension of Mengovirus (10 pm/cell). After permit- 
ting virus to adsorb for 1 hr, the medium is replaced by fresh 
medium containing actinomycin (2-3 fig/ml). Left: Directly 
after the change of medium 1evaJlorphan isadded at the con- 
centrations shown, followed immediately by 3H-uridine (0.2 
M/ml, 2 MCi/ml) and thymidine (0.05 &ml). Right: The cul- 
tures are incubated for 3 hr after changing media, before ad- 
dition of levallorphan, 3H-uridine and thymidine as above. The 
cells are collected at 1,3 and 5 hr and the incorporation of ra- 
dioactivity into material insoluble in 5% trichloracetic acid 
is measured in a scintillation counter. The time scale represents 
hours after the end of the virus adsorption period. Ieft - 
control Mego virus + actmomycin; O----O control actinomycin 
alone -A levallorphan 5 X 10-4 M; x--x 1evaBorphan 
1 x 10-3 M right - control Mengo virus RNA + actinomy- 
tin; x-x levallorphan 7.5 X 104 M. 
phan inhibits the formation of RNA by Lcells. How- 
ever, the equal susceptibility of viral and cellular RNA 
synthesis uggests hat the inhibition of nucleic acid 
synthesis i  a secondary consequence of some other 
effect on the cell. A less likely alternative isthat the 
synthesis of DNA, DNA-directed RNA and RNAde- 
pendent RNA have certain intrinsic characteristics in 
common which render them equally susceptible to 
the action of the drug. 
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